Sustained release topiramate
Patent Information
- Authority / Receiving Office
- US ยท United States
- Current Assignee / Owner
- R T ALAMO VENTURES
- Publication Date
- 2003-04-17
- Estimated Expiration
- Not applicable ยท inactive patent
Smart Images

Figure 1 
Figure 2
Abstract
Description
[0001] The present invention relates to the use of a sustained-release formulation of topiramate for the treatment of mania, depression and bipolar disorder.BACKGROUND OF INVENTION
[0002] Manic depression involves wide mood alterations, with periods of both depression and mania. A person experiencing depression or mania may have intense mood swings and consequent changes in thinking and behavior. The term that is professionally used for this illness is Bipolar Affective Disorder. Bipolar means sharing two poles (high and low) and Affective Disorder means a disorder having to do with mood.
[0003] The cause of manic depression is not known. Manic depression can send a person plunging from a high state, where one may believe one has superhuman energy and abilities, into a pit of despair, where it may seem as if the only way out is suicide. It is estimated that 1% of the population will have a manic-depressive illness. The number of manic and depressive episodes varies greatly from person...